Conferences
30 May 2022, Online
Biomolecules Webinar | Role of NRF2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches II
Since it was discovered, the transcription factor (nuclear factor erythroid-2-related factor 2) NRF2 has been implicated in processes associated with redox balance, inflammation, proteostasis and lipids, purines and pentoses metabolism, becoming a pleiotropic transcription factor. For this reason, NRF2 has developed as a polyvalent target against various pathologies, where the signaling system of NRF2 is altered. This webinar will expose the relevance of the transcription factor in the development of different pathologies and how the modulation of this pathway can have therapeutic implications.
The following experts will be present and talk:
- Dr. Isabel Lastres-Becker, Department of Biochemistry, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain | Instituto de Investigaciones Biomédicas "Alberto Sols", UAM-CSIC, Madrid, Spain,
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain,
Instituto de Investigación Sanitaria La Paz (IdiPaz), Madrid, Spain | Institute Teófilo Hernando for Drug Discovery, Universidad Autónoma de Madrid, Madrid, Spain - Prof. Dr. Antonio Cuadrado, Department of Biochemistry, Medical College, Autonomous University of Madrid, Spain
- Dr. Albena T. Dinkova-Kostova, Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom
- Prof. Dr. Giles E. Hardingha, UK Dementia Research Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom
When? 30 May 2022 at 2:00 pm CEST | 8:00 am EDT | 8:00 pm CST Asia
Register now for free!
Interested in contributing to the topic? You can find the Special Issue(s) linked to this topic and open for submission by clicking here.
